Dr. Miguel Francisco Manzur, MD

Dr. Manzur practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Manzur's NPI, 1336560085, was assigned on December 25, 2013. Dr. Manzur graduated from Keck School of Medicine of USC in 2012. Dr. Manzur holds California license A127911.

Dr. Manzur's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Manzur's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Manzur is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Manzur to 2 more hospitals, 1 group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manzur practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Manzur's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Manzur is board certified in surgery by the American Board of Surgery. Dr. Manzur is licensed in California.

Dmand AI lists arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Manzur treats.

CMS data shows 1,874 Medicare services from Dr. Manzur across 31 procedure codes in 2024, for 889 Medicare patients. Medicare paid $181,607 for them.

CMS counts 889 Medicare patients who saw Dr. Manzur in 2024. The largest group is 65 to 74, with 330 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 3.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manzur's median patient age at 67, with 45% women.

In 2024, Dr. Manzur wrote 84 Medicare Part D claims for 43 patients. 57% of them were for generic drugs. CMS names the drug for 44 of them, across 3 drugs with 11 or more claims each, at $8,536 in total drug cost. In 2023, CMS named 80 claims across 5 drugs.

Dr. Manzur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of leg revascularization (restoring blood flow) by Dr. Manzur, more than 94% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Manzur, published from 2016 to 2021. Dr. Manzur's most frequent co-authors are Sukgu Michael Han, MD, Fred A. Weaver, MD and Fernando Fleischman, MD.

CMS Open Payments shows 426 general payments to Dr. Manzur from 36 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 35% of the total. Stryker Corporation paid the most, $26,990.

Dr. Manzur graduated from Keck School of Medicine of USC in 2012.

Dr. Manzur is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.